News

The deal leverages Xenon’s Extreme Genetics discovery platform to focus on rare phenotypes where individuals have an inability to perceive pain or where individuals have non-precipitated spontaneous severe

In 2013, Golden State Foods (GSF), a diversified food processors and distributors in the US, acquired a controlling interest in KanPak, a supplier of beverages and desserts using

MST-188 has already secured FDA orphan drug designation for the treatment of ALI, an acute complication of peripheral arterial disease that describes a sudden decrease in perfusion of

The new solution is aimed at helping providers and communities reduce hospital readmissions and re-incarcerations as well as help create more comprehensive patient health records. As of now,

NeoStem Grants and Academic Liaison director Dr Denis O. Rodgerson and Dr Vincent Falanga, The Barbara A. Gilchrest Professor of Dermatology and Professor of Biochemistry at the Boston

Proceeds from the financing will be used to further develop its first two pharmaceutical products and its associated drug delivery technology. The first product is a novel drug-device

Recruitment was temporarily paused due to a drug storage issue which has now been resolved to the satisfaction of the UK Regulatory Body, allowing the trial to continue

Access recently submitted an additional patent application to protect improvements in the technology and expand applications, and is actively seeking development partners globally. Access compared single doses of

Currently, Precision is advancing its clinical trials with NEO-102, which is being developed as a therapeutic drug candidate for pancreatic and colorectal cancers. As part of the deal,